Hvsen Biotechnology Co., Ltd. (300871.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap4.19B
Enterprise Value4.08B
P/E Ratio12.43
PEG Ratio0.13
Price/Sales Ratio2.46
Price/Book Ratio1.84
Enterprise/Revenue2.52
Enterprise/EBITDA10.07

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.2
Operating Margin0.23
AD

Management Effectiveness

Return On Assets0.1
Return On Equity0.15

Income Statement

Revenue1.68B
Revenue/Share8.51
Gross Profit520.99M
EBITDA422.63M
Net Income253.16M
Diluted EPS1.25

Balance Sheet

Total Cash573.18M
Total Cash/Share2.83
Total Debt463.83M
Total Debt/Equity0.2
Current Ratio2.05
Book Value Per Share11.48

Price History

52-Week Change-6.38
52-Week High32.62
52-Week Low19.08
Moving Average 50 Days22.58
Moving Average 200 Days23.95

Statistics

Average Volume6.87M
Shares Outstanding201.78M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.5
Trailing Annual Dividend Yield2.38
Payout Ratio0.01
Last Split Factor3:2
Last Split DateMay 10, 2021
AD